Generation Bio Co. Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	72.24	98.86	380.84	64.94	15.13	7.36
Short-Term Investments	197.92	185.92	0	199.44	0	67.57
Cash & Cash Equivalents	270.16	284.78	380.84	264.38	15.13	74.92
Cash Growth	-5.14%	-25.22%	44.05%	1647.26%	-79.80%	-
Receivables	3.96	0.4	0	0	0.45	1.29
Other Current Assets	-1.5	1.84	-1.65	3.36	2.58	0.71
Total Current Assets	272.62	287.02	379.19	267.74	18.16	76.93
Property, Plant & Equipment	95.65	81.42	91.03	23.78	21.85	4.49
Other Long-Term Assets	6.49	7.83	6.56	2.64	2.14	2.11
Total Long-Term Assets	102.14	89.25	97.59	26.42	23.98	6.59
Total Assets	374.76	376.26	476.77	294.16	42.14	83.52
Accounts Payable	2.35	0.66	2.02	0.27	2.25	1.68
Deferred Revenue	54.86	0	0	0	0	0
Current Debt	8.12	7.09	4.61	0	0	0
Other Current Liabilities	-25.41	11.4	12.18	10.95	6.91	4.87
Total Current Liabilities	39.91	19.15	18.81	11.22	9.16	6.56
Long-Term Debt	89.77	74.62	76.22	0	0	0
Other Long-Term Liabilities	41.94	0	0	14.92	15.98	2.96
Total Long-Term Liabilities	131.72	74.62	76.22	14.92	15.98	2.96
Total Liabilities	171.63	93.77	95.03	26.14	25.14	9.52
Total Debt	97.89	81.71	80.83	0	0	0
Debt Growth	19.81%	1.09%	-	-	-	-
Retained Earnings	-571.38	-444.77	-308.13	-188.98	-108.45	-47.14
Comprehensive Income	0.27	-0.08	0	0.01	0	-0.01
Shareholders' Equity	203.13	282.49	381.75	268.01	-98.59	-41.59
Net Cash / Debt	172.26	203.08	300.01	264.38	15.13	74.92
Net Cash / Debt Growth	-15.17%	-32.31%	13.48%	1647.26%	-79.80%	-
Net Cash Per Share	2.67	3.49	5.33	9.70	3.20	22.36
Working Capital	232.7	267.87	360.38	256.52	9	70.37
Book Value Per Share	3.15	4.86	6.78	9.83	-20.84	-12.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).